| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.018 | 0.9 |